Holocene Advisors
NVO

Holocene Advisors’s Novo Nordisk NVO Stock Holding History

Holocene Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,745,580
Closed -$64.2M – 948
2026
Q1 		$64.2M Buy
1,745,580
+565,080
+48% +$26.8M 0.15% 156
2025
Q4 		$60.1M Buy
+1,180,500
New +$60.4M 0.13% 187
2025
Q3 		– Sell
-373,010
Closed -$25.7M – 866
2025
Q2 		$25.7M Buy
+373,010
New +$25.4M 0.06% 224
2024
Q3 		– Sell
-24,653
Closed -$3.52M – 816
2024
Q2 		$3.52M Buy
+24,653
New +$3.27M 0.01% 393
2024
Q1 		– Sell
-596,996
Closed -$61.8M – 824
2023
Q4 		$61.8M Buy
+596,996
New +$59M 0.24% 130
2023
Q2 		– Sell
-42,784
Closed -$3.4M – 818
2023
Q1 		$3.4M Buy
+42,784
New +$3.03M 0.02% 344

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Holocene Advisors's NVO Position: Q2 2026 in Review

Holocene Advisors sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 1,745,580 shares — an estimated $64.2M sold.

Holocene Advisors first reported a position in NVO in Q1 2023 and held it in 6 quarters. The position peaked at $64.2M in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Holocene Advisors reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Holocene Advisors sold 1,745,580 Novo Nordisk shares in Q2 2026, an estimated $64.2M.
  • Holocene Advisors first reported a position in Novo Nordisk in Q1 2023 and held it in 6 quarters.
  • Holocene Advisors's Novo Nordisk position peaked at $64.2M in Q1 2026.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.